CIK 0001822791
- Non-accelerated filer
- Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 852828339
- Phone
- +1 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Kiernan Matthew Director | Grant or award · stock option | +3,086 | 3,086 | ||
| 2026-08-13 | Kiernan Matthew Director | Grant or award · stock option | +3,195 | 3,195 | ||
| 2026-05-21 | Kiernan Matthew Director | Grant or award · stock option | +1,500 | 1,500 | ||
| 2026-05-21 | Kiernan Matthew Director | Grant or award · stock option | +1,876 | 1,876 | ||
| 2026-02-19 | Kiernan Matthew Director | Grant or award · stock option | +2,755 | 2,755 | ||
| 2025-11-13 | Kiernan Matthew Director | Grant or award · stock option | +1,893 | 1,893 | ||
| 2025-08-14 | Kiernan Matthew Director | Grant or award · stock option | +3,720 | 3,720 | ||
| 2025-05-22 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +1,500 | 1,500 | ||
| 2025-05-22 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +5,236 | 5,236 | ||
| 2025-02-27 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +2,886 | 2,886 | ||
| 2024-12-06 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +2,853 | 2,853 | ||
| 2024-10-02 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +2,559 | 2,559 | ||
| 2024-06-07 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +33,704 | 33,704 | ||
| 2024-05-29 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +30,000 | 30,000 | ||
| 2024-03-11 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +29,481 | 29,481 | ||
| 2023-11-28 | Kiernan Matthew Director | Grant or award · Stock Options (Right to buy) | +28,730 | 28,730 |
Page 1 of 1 · 16 trades